ArticleJournal of translational medicine2024

Getting more bang for their buck: BCL2 inhibitors boost dendritic-cell function to enhance anti-cancer immune surveillance.

Alfredo E Montes-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.